Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Ryan D Kilpatrick"'
Autor:
Olga Sánchez-Soliño, Ryan D. Kilpatrick, Christopher Johnson, Yixin Fang, Yizhou Ye, Negar Niki Alami, Katarzyna Zarish, Whitney S. Krueger, Nancy Dreyer, Gregory C. Gray
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 4, Pp 633-645 (2024)
Abstract Introduction This prospective, longitudinal, community-based study, EpidemiologiCal POpulatioN STudy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Lake CounTy, Illinois (CONTACT), investigated coronavirus disease 2019 (C
Externí odkaz:
https://doaj.org/article/040e2341a90a4befb2010731d663dd47
Autor:
Huifang Liang, Brenna Kirk, Jennifer M. Polinski, Xiaomeng Yue, Ryan D. Kilpatrick, Joel M. Gelfand
Publikováno v:
JID Innovations, Vol 3, Iss 2, Pp 100171- (2023)
This study investigated whether systemic drug prescribing for psoriasis varies by season and other exacerbating factors. Eligible patients with psoriasis were assessed for each season for initiation, discontinuation, and switching of systemic drugs.
Externí odkaz:
https://doaj.org/article/6c278893ac5a43aa94499cc6919a6a0c
Autor:
Ryan D. Kilpatrick, Olga Sánchez-Soliño, Negar Niki Alami, Christopher Johnson, Yixin Fang, Lani R. Wegrzyn, Whitney S. Krueger, Yizhou Ye, Nancy Dreyer, Gregory C. Gray
Publikováno v:
Infectious Diseases and Therapy
Introduction EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois (CONTACT) is an observational, epidemiological study with a 9-month longitudinal follow-up of nonhospitalized persons aged 18 years or older currently living or empl
Publikováno v:
British Journal of Clinical Pharmacology.
Autor:
Debasish Mazumder, Ryan D. Kilpatrick, Ravi Potluri, Alexander Liede, Jerzy Edward Tyczynski, Anirban Ghosh
Publikováno v:
Oncology and Therapy
Introduction The incidence of pneumonitis, a treatment-related adverse event (AE) in non-small cell lung cancer (NSCLC) patients, has been studied in the United States mostly through clinical trials and retrospective chart reviews. Few analyses of re
Autor:
Seoyoung C. Kim, Soo Kyung Cho, Joseph F. Merola, Ryan D. Kilpatrick, Angela Y. Tong, Lani R. Wegrzyn, Hemin Lee, Lily G. Bessette, Mengdong He
Publikováno v:
Pharmacoepidemiology and Drug Safety. 30:868-874
Purpose Accurately identifying patients with psoriasis (PsO) is crucial for generating real-world evidence on PsO disease course and treatment utilization. Methods We developed 9 claims-based algorithms for PsO using a combination of the Internationa
Autor:
Inyoung Lee, Jeremy D. Jokinen, Stephanie Y. Crawford, Ryan D. Kilpatrick, Todd A. Lee, Gregory S. Calip
Publikováno v:
Therapeutic Innovation & Regulatory Science. 55:142-151
Completeness of adverse event (AE) reports is an important component of quality for good pharmacovigilance practices. We aimed to evaluate the impact of incorporating a measure of completeness of AE reports on quantitative signal detection. An intern
Autor:
Nelson B. Watts, Lani R. Wegrzyn, Cheryl Xiang, Stephanie E Chiuve, Michael C. Snabes, William D s, Wei Gao, Jia Zhong, Ahmed M Soliman, Ryan D. Kilpatrick, Hongbo Yang, Sarah H. Koenigsberg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c78f5a1d610c8225035d3ccc25c9e305
https://doi.org/10.1002/jbm4.10401/v2/response1
https://doi.org/10.1002/jbm4.10401/v2/response1
Autor:
Jeremy D. Jokinen, Todd A. Lee, Stephanie Y. Crawford, Inyoung Lee, Gregory S. Calip, Ryan D. Kilpatrick
Publikováno v:
Expert opinion on drug safety. 19(10)
Marketing authorization holder (MAH)-sponsored patient support programs (PSPs) are a major source of adverse event (AE) reports. The impact of reports from PSPs on the ability to detect AE signals is unclear. We compared signal detection performance
Autor:
Ryan D. Kilpatrick, Hongbo Yang, Wei Gao, Jia Zhong, Stephanie E Chiuve, Sarah H. Koenigsberg, Michael C. Snabes, William D. Leslie, Ahmed M. Soliman, Cheryl Xiang, Lani R. Wegrzyn, Nelson B. Watts
Publikováno v:
JBMR Plus
Elagolix, a gonadotrophin‐releasing hormone antagonist, is used in premenopausal women with endometriosis. There is a risk of bone loss with elagolix, but the long‐term effects of BMD loss later in life cannot be directly assessed and has not bee